|
US6350758B1
(en)
*
|
1996-12-02 |
2002-02-26 |
Georgetown University |
Tropane derivatives and method for their synthesis
|
|
WO1999065492A1
(en)
|
1998-06-19 |
1999-12-23 |
Eli Lilly And Company |
Inhibition of serotonin reuptake
|
|
US6218383B1
(en)
*
|
1998-08-07 |
2001-04-17 |
Targacept, Inc. |
Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
|
|
ATE259804T1
(de)
*
|
1998-11-27 |
2004-03-15 |
Neurosearch As |
8-azabicyclo(3.2.1)okt-2-en- und -oktanderivate
|
|
US6953855B2
(en)
|
1998-12-11 |
2005-10-11 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
|
US6432975B1
(en)
*
|
1998-12-11 |
2002-08-13 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
AU2278700A
(en)
|
1999-01-28 |
2000-08-18 |
Neurosearch A/S |
Novel azabicyclo derivatives and their use
|
|
US7265115B2
(en)
|
1999-01-29 |
2007-09-04 |
Abbott Laboratories |
Diazabicyclic CNS active agents
|
|
ES2305373T3
(es)
*
|
1999-01-29 |
2008-11-01 |
Abbott Laboratories |
Derivados diazabiciclicos como ligandos del receptor nicotinico de la acetilcolina.
|
|
NZ513575A
(en)
|
1999-05-04 |
2003-07-25 |
Neurosearch As |
Heteroaryl diazabicycloalkanes useful for treating or preventing a disease or a disorder responsive to the activity of nAChR modulators
|
|
US6890935B2
(en)
|
1999-11-01 |
2005-05-10 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
MY145722A
(en)
*
|
2000-04-27 |
2012-03-30 |
Abbott Lab |
Diazabicyclic central nervous system active agents
|
|
NZ522793A
(en)
|
2000-07-04 |
2005-02-25 |
Neurosearch As |
Aryl and heteroaryl diazabicycloalkanes, their preparation and use
|
|
CN100398103C
(zh)
*
|
2000-10-13 |
2008-07-02 |
神经研究公司 |
通过烟碱性受体激动剂和单胺能物质的联合作用治疗情感性精神障碍
|
|
CA2462453C
(en)
*
|
2001-10-02 |
2009-07-28 |
Pharmacia & Upjohn Company |
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
|
|
DE10164139A1
(de)
|
2001-12-27 |
2003-07-10 |
Bayer Ag |
2-Heteroarylcarbonsäureamide
|
|
CA2476681A1
(en)
|
2002-02-19 |
2003-08-28 |
Bruce N. Rogers |
Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease
|
|
CN100522976C
(zh)
*
|
2002-05-07 |
2009-08-05 |
神经研究公司 |
氮杂环乙炔基衍生物
|
|
GB2398636A
(en)
*
|
2003-02-21 |
2004-08-25 |
Ipsen Ltd |
Method for determining the quantity of pre-synaptic neuromuscular blocking substance contained in a sample
|
|
DE602004013427T2
(de)
*
|
2003-02-28 |
2009-06-04 |
Schering Corp. |
Biaryltetrahydroisochinolin-piperidine als selektive mch-rezeptor-antagonisten zur behandlung von adipositas und verwandten erkrankungen
|
|
KR100767854B1
(ko)
|
2003-03-12 |
2007-10-17 |
화이자 프로덕츠 인크. |
피리딜옥시메틸 및 벤즈이속사졸 아자비시클릭 유도체
|
|
AU2005284908B2
(en)
|
2004-09-13 |
2011-12-08 |
Morningside Venture Investments Limited |
Biosynchronous transdermal drug delivery
|
|
US20060173037A1
(en)
*
|
2005-01-10 |
2006-08-03 |
Nathalie Schlienger |
Aminophenyl derivatives as selective androgen receptor modulators
|
|
US7662812B2
(en)
|
2005-02-16 |
2010-02-16 |
Neurosearch A/S |
Diazabicyclic aryl derivatives and their use as chinolinergic ligands at nicotinic acetylcholine receptors
|
|
DE102005007859A1
(de)
*
|
2005-02-21 |
2006-08-24 |
Lts Lohmann Therapie-Systeme Ag |
Vefahren für eine medikamentöse Kombinations-Behandlung, sowie hierfür geeignete Arzneimittel-Kombinationen
|
|
EP1869034A1
(en)
*
|
2005-04-08 |
2007-12-26 |
NeuroSearch A/S |
(+) - and (-) -8-alkyl-3-(trifluoralkylsulfonyloxy)-8-azabicycl (3.2.1.)oct-2-ene
|
|
FR2889701B1
(fr)
*
|
2005-08-12 |
2007-10-05 |
Sanofi Aventis Sa |
Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.
|
|
ATE473978T1
(de)
|
2005-12-06 |
2010-07-15 |
Neurosearch As |
Neue diazabicyclische arylderivate und medizinische verwendung dafür
|
|
US20070134169A1
(en)
*
|
2005-12-11 |
2007-06-14 |
Rabinoff Michael D |
Methods for smoking cessation or alcohol cessation or other addiction cessation
|
|
AU2007213670A1
(en)
|
2006-02-10 |
2007-08-16 |
Neurosearch A/S |
3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
|
|
WO2007090888A1
(en)
|
2006-02-10 |
2007-08-16 |
Neurosearch A/S |
3-heteroaryl- 3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists
|
|
CN101379063A
(zh)
|
2006-02-10 |
2009-03-04 |
神经研究公司 |
3,9-二氮杂双环[3.3.1]壬烷衍生物及其作为单胺神经递质再摄取抑制剂的用途
|
|
MX2008014296A
(es)
*
|
2006-06-12 |
2009-03-06 |
Pfizer Prod Inc |
Antagonista de ccr5 para mejorar la restitucion inmunitaria y tratar la infeccion oportunista en pacientes con vih.
|
|
CN103977003A
(zh)
|
2007-04-02 |
2014-08-13 |
帕金森氏病研究院 |
用于降低治疗的副作用的方法和组合物
|
|
TWI415850B
(zh)
*
|
2007-07-20 |
2013-11-21 |
Theravance Inc |
製備ｍｕ類鴉片受體拮抗劑之中間物的方法
|
|
SA08290475B1
(ar)
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
|
US8697722B2
(en)
*
|
2007-11-02 |
2014-04-15 |
Sri International |
Nicotinic acetylcholine receptor modulators
|
|
ES2439767T3
(es)
*
|
2008-08-01 |
2014-01-24 |
Purdue Pharma Lp |
Compuestos de tetrahidropiridinilo y dihidropirrolilo y uso de los mismos
|
|
AU2009317348A1
(en)
*
|
2008-11-18 |
2010-05-27 |
Neurosearch A/S |
8-azabicyclo [3.2.1]oct-2-ene derivatives and their use as mono-amine neurotransmitter re-uptake inhibitors
|
|
LT2889033T
(lt)
|
2008-11-19 |
2018-07-10 |
Forum Pharmaceuticals Inc. |
Šizofrenijos negatyvių simptomų gydymas (r)-7-chlor-n-(chinuklidin-3-il)benzo[b]tiofen-2-karboksamidu ir jo farmaciniu požiūriu priimtinomis druskomis
|
|
TW201031664A
(en)
|
2009-01-26 |
2010-09-01 |
Targacept Inc |
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
|
|
JP5808319B2
(ja)
*
|
2009-05-11 |
2015-11-10 |
フォルム ファーマシューティカルズ、インコーポレイテッド |
アセチルコリンエステラーゼ阻害剤と組み合わせた特定のα７ニコチン酸受容体を用いた認知障害の治療
|
|
RU2560729C2
(ru)
|
2010-01-11 |
2015-08-20 |
АСТРАЕА ТЕРАПЕУТИКС, ЭлЭлСи |
Модуляторы никотиновых ацетилхолиновых рецепторов
|
|
PE20170923A1
(es)
|
2010-05-17 |
2017-07-12 |
Forum Pharmaceuticals Inc |
Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida monohidratado
|
|
EP3461481A1
(en)
|
2012-05-08 |
2019-04-03 |
Forum Pharmaceuticals Inc. |
Methods of maintaining, treating or improving cognitive function
|
|
WO2014011768A1
(en)
*
|
2012-07-10 |
2014-01-16 |
Adispell, Inc. |
Anti-anxiety treatment
|
|
AU2016211330A1
(en)
|
2015-01-28 |
2017-08-03 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
|
US9724340B2
(en)
|
2015-07-31 |
2017-08-08 |
Attenua, Inc. |
Antitussive compositions and methods
|
|
CA3049529A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
US11596779B2
(en)
|
2018-05-29 |
2023-03-07 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
US12397141B2
(en)
|
2018-11-16 |
2025-08-26 |
Morningside Venture Investments Limited |
Thermally regulated transdermal drug delivery system
|
|
KR102272452B1
(ko)
|
2020-12-11 |
2021-07-05 |
(주)예광솔라 |
스파이럴 파일 공법 및 이에 적용되는 스파이럴 파일
|
|
KR200497569Y1
(ko)
|
2021-02-18 |
2023-12-21 |
주식회사 알파인랩 |
지주 기초용 스크루 파일
|